Vijaya Diagnostic Centre Ltd

With a decisive surge to Rs 1576.9 on 09 Sep 2026, Vijaya Diagnostic Centre Ltd has reached a fresh 52-week high, marking a 40.91% gain over the past year. This milestone comes amid a backdrop of broad technical alignment and sustained price momentum, even as the broader Sensex trades near its 52-week low.

Vijaya Diagnostic Centre Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 11 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 03 September 2026, providing investors with the most recent and relevant data to assess the company’s prospects.

Vijaya Diagnostic Centre Ltd is rated Buy by MarketsMOJO, with this rating last updated on 11 August 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 23 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Surpassing its previous peaks, Vijaya Diagnostic Centre Ltd touched a new 52-week high of Rs 1545.55 on 13 Jun 2026, marking a 42.36% gain over the past year and significantly outperforming the Sensex, which declined by 3.49% during the same period.

The Sensex declined by 0.24% on 12 Aug 2026 while Vijaya Diagnostic Centre Ltd surged 7.25%, reaching a new 52-week and all-time high of Rs 1529.5. This 9.54-percentage-point outperformance against the Hospital & Healthcare Services sector, which fell 2.28%, highlights a distinctly stock-specific rally rather than a market-wide uplift.

Surging past its previous peaks, Vijaya Diagnostic Centre Ltd touched a new 52-week high of Rs 1494.9 on 12 Aug 2026, marking a significant milestone in its price momentum. This breakout comes amid a sustained three-day rally that has propelled the stock up by 9.45%, outpacing its sector by 4.83% on the day.

Vijaya Diagnostic Centre Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. The healthcare services company’s robust quarterly results, bullish technical signals, and consistent long-term returns have collectively driven this positive reassessment by MarketsMOJO.

Vijaya Diagnostic Centre Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its MarketsMOJO rating from Hold to Buy. The healthcare services small-cap stock has outperformed the Sensex significantly over multiple timeframes, signalling renewed investor confidence and a positive outlook for the company’s near-term trajectory.

Vijaya Diagnostic Centre Ltd, a small-cap player in the Healthcare Services sector, has experienced a nuanced shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a modest day gain of 0.57%, the stock’s technical indicators present a mixed picture, signalling cautious optimism for investors as it navigates fluctuating market dynamics.

Vijaya Diagnostic Centre Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 August 2026, providing investors with the latest insights into its performance and prospects.

Vijaya Diagnostic Centre Ltd is rated Buy by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 July 2026, providing investors with the latest insights into its performance and outlook.

With a 40.65% gain over the past year, Vijaya Diagnostic Centre Ltd has surged to a fresh 52-week high of Rs 1433.7 on 16 Jul 2026, significantly outperforming the Sensex which declined 6.59% over the same period. This milestone reflects a sustained rally fuelled by strong technical momentum and supportive fundamentals.

Vijaya Diagnostic Centre Ltd is rated Buy by MarketsMOJO, with this rating last updated on 08 June 2026. While the rating was revised on that date, the analysis and financial metrics presented here reflect the company’s current position as of 12 July 2026, providing investors with the latest insights into its performance and outlook.

Vijaya Diagnostic Centre Ltd is rated Buy by MarketsMOJO, with this rating last updated on 08 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 01 July 2026, providing investors with the latest insights into its performance and outlook.

Vijaya Diagnostic Centre Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 June 2026, providing investors with the latest insights into its performance and outlook.

Vijaya Diagnostic Centre Ltd is rated Buy by MarketsMOJO, with this rating last updated on 08 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.

Vijaya Diagnostic Centre Ltd, a small-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent day decline of 2.92%, the stock’s broader technical indicators present a nuanced picture, reflecting both strength and caution for investors navigating this evolving landscape.